USMLE Hematology-Oncology: Thrombocytopenia (ITP, TTP, HIT, DIC) – Distinguishing Features

What This Is and Why It Matters for USMLE

Thrombocytopenia: ITP, TTP, HIT, DIC — Distinguishing Features is a high-yield topic for Step 1, Step 2 CK, and Step 3. It appears in basic science, clinical, and ethics/management contexts, with a high frequency in Step 2 CK and Step 3. Understanding these conditions is crucial for managing patients with bleeding disorders.

High-Yield Facts (What You Must Memorize)

• Pathophysiology:
  • ITP: autoimmune destruction of platelets
  • TTP: microangiopathic hemolytic anemia, thrombocytopenia, renal failure, and neurological symptoms
  • HIT: immune response to heparin, leading to thrombocytopenia and thrombosis
  • DIC: consumption of platelets and coagulation factors, leading to bleeding and thrombosis
• Classic presentation and physical exam findings:
  • ITP: petechiae, purpura, and bleeding gums
  • TTP: neurological symptoms (e.g., headache, confusion), renal failure, and microangiopathic hemolytic anemia
  • HIT: thrombocytopenia, thrombosis (e.g., DVT, PE), and heparin-induced antibodies
  • DIC: bleeding, thrombosis, and organ failure
• Diagnostic approach:
  • ITP: platelet count, PT, PTT, and RBC count
  • TTP: platelet count, PT, PTT, RBC count, and ADAMTS13 activity
  • HIT: platelet count, PT, PTT, and heparin-induced antibody test
  • DIC: platelet count, PT, PTT, RBC count, and fibrinogen level
• First-line treatment and management:
  • ITP: corticosteroids, IVIG, and platelet transfusions
  • TTP: plasma exchange, corticosteroids, and anti-platelet agents
  • HIT: heparin discontinuation, corticosteroids, and anti-platelet agents
  • DIC: corticosteroids, anticoagulants, and supportive care
• Red flags, complications, and follow-up:
  • ITP: bleeding, infection, and splenomegaly
  • TTP: neurological symptoms, renal failure, and microangiopathic hemolytic anemia
  • HIT: thrombosis, bleeding, and heparin-induced antibodies
  • DIC: bleeding, thrombosis, and organ failure

Clinical Pearls & Buzzwords

• Thrombocytopenia-ITP, TTP, HIT, DIC
• Microangiopathic hemolytic anemia-TTP, DIC
• Heparin-induced antibodies-HIT
• Platelet count-ITP, TTP, HIT, DIC

Step-by-Step Clinical Reasoning

1. Identify the syndrome or presentation (e.g., thrombocytopenia, bleeding, thrombosis)
2. Generate a differential (most likely and must-not-miss):
   • ITP, TTP, HIT, DIC
   • Other causes of thrombocytopenia (e.g., sepsis, cancer, medications)
3. Order appropriate initial tests:
   • Platelet count, PT, PTT, RBC count, and fibrinogen level
   • ADAMTS13 activity (TTP)
   • Heparin-induced antibody test (HIT)
4. Interpret results:
   • ITP: low platelet count, normal PT and PTT
   • TTP: low platelet count, normal PT and PTT, and low ADAMTS13 activity
   • HIT: low platelet count, normal PT and PTT, and heparin-induced antibodies
   • DIC: low platelet count, prolonged PT and PTT, and low fibrinogen level
5. Initiate treatment and monitoring:
   • ITP: corticosteroids, IVIG, and platelet transfusions
   • TTP: plasma exchange, corticosteroids, and anti-platelet agents
   • HIT: heparin discontinuation, corticosteroids, and anti-platelet agents
   • DIC: corticosteroids, anticoagulants, and supportive care

Common Mistakes & Exam Traps

• The mistake: Failing to consider TTP in patients with thrombocytopenia and microangiopathic hemolytic anemia.
• Why it happens: Misunderstanding of TTP presentation and pathophysiology.
• How to avoid it: Consider TTP in patients with thrombocytopenia, microangiopathic hemolytic anemia, and neurological symptoms.

• Exam board insight: TTP is a common cause of thrombocytopenia in patients with neurological symptoms.

• The mistake: Failing to diagnose HIT in patients with thrombocytopenia and heparin use.

• Why it happens: Misunderstanding of HIT presentation and pathophysiology.
• How to avoid it: Consider HIT in patients with thrombocytopenia and heparin use, and order heparin-induced antibody test.

• Exam board insight: HIT is a common cause of thrombocytopenia in patients with heparin use.

• The mistake: Failing to manage DIC with corticosteroids and anticoagulants.

• Why it happens: Misunderstanding of DIC management.
• How to avoid it: Manage DIC with corticosteroids and anticoagulants, and monitor for bleeding and thrombosis.
• Exam board insight: DIC is a life-threatening condition that requires prompt management.

How It’s Tested on USMLE

• Step 1: Basic science vignette (e.g., molecular mechanism, pathology slide, pharmacology)
• Step 2 CK: Clinical vignette (e.g., "A 45-year-old with thrombocytopenia and bleeding...")
• Step 3: Similar to Step 2 CK, plus prognosis, risk factors, and occasionally CCS management

CCS (Step 3) Relevance (If Applicable)

• Initial orders: platelet count, PT, PTT, RBC count, and fibrinogen level
• Monitoring and follow-up: platelet count, PT, PTT, RBC count, and fibrinogen level, and heparin-induced antibody test (HIT)
• Common mistakes: failing to consider TTP and HIT in patients with thrombocytopenia and bleeding.

Practice Questions (3-5 single-best-answer)

Question 1: A 30-year-old woman with ITP presents with petechiae and purpura. Which of the following is the most appropriate initial treatment? A) Corticosteroids B) IVIG C) Platelet transfusions D) Splenectomy

Answer: A) Corticosteroids

Explanation: Corticosteroids are the first-line treatment for ITP, with IVIG and platelet transfusions reserved for severe cases.

Question 2: A 40-year-old man with TTP presents with thrombocytopenia, microangiopathic hemolytic anemia, and neurological symptoms. Which of the following is the most appropriate initial treatment? A) Plasma exchange B) Corticosteroids C) Anti-platelet agents D) Heparin

Answer: A) Plasma exchange

Explanation: Plasma exchange is the most appropriate initial treatment for TTP, with corticosteroids and anti-platelet agents used in conjunction.

Question 3: A 50-year-old woman with HIT presents with thrombocytopenia and heparin-induced antibodies. Which of the following is the most appropriate initial treatment? A) Heparin discontinuation B) Corticosteroids C) Anti-platelet agents D) Warfarin

Answer: A) Heparin discontinuation

Explanation: Heparin discontinuation is the most appropriate initial treatment for HIT, with corticosteroids and anti-platelet agents used in conjunction.

Quick Reference Card (60-Second Summary)

• ITP: autoimmune destruction of platelets, petechiae, purpura, and bleeding gums
• TTP: microangiopathic hemolytic anemia, thrombocytopenia, renal failure, and neurological symptoms
• HIT: heparin-induced antibodies, thrombocytopenia, and thrombosis
• DIC: consumption of platelets and coagulation factors, leading to bleeding and thrombosis
• Corticosteroids, IVIG, and platelet transfusions for ITP
• Plasma exchange, corticosteroids, and anti-platelet agents for TTP
• Heparin discontinuation, corticosteroids, and anti-platelet agents for HIT
• Corticosteroids, anticoagulants, and supportive care for DIC

If You Get Stuck on Test Day

• Eliminate obviously wrong answers
• Use the "next best step" hierarchy (least invasive, most specific)
• For Step 3 CCS: order basic labs, vitals, and IV access when unsure.

Related USMLE Topics

• Thrombosis: connects to HIT, DIC, and anticoagulant therapy
• Bleeding disorders: connects to ITP, TTP, and DIC
• Coagulation disorders: connects to DIC, HIT, and anticoagulant therapy